Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
Sign Up to like & getrecommendations! Published in 2017 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-017-4479-y
Abstract: PurposeThe updated 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing have made some major changes in HER2 fluorescence in situ hybridization (FISH) interpretation… read more here.
Keywords: repeat her2; her2 testing; equivocal cases; her2 fish ... See more keywords
Effect of EDTA Decalcification on ER and PR Immunohistochemistry and HER2/neu Fluorescence In Situ Hybridization in Breast Carcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Human pathology"
DOI: 10.1016/j.humpath.2021.08.007
Abstract: Bone is the most common site of metastasis in breast carcinoma (BC). Treatments for metastatic BC depend on various factors including the tumor's estrogen receptor (ER), progesterone receptor (PR), and HER2 status. Bone biopsies require… read more here.
Keywords: ihc her2; breast carcinoma; decalcification; her2 fish ... See more keywords
HER2 testing: Insights from pathologists’ perspective on challenging HER2 cases.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e12512
Abstract: e12512 Background: HER2 status dictates treatment decisions in breast cancer making the precision and accuracy of laboratory testing essential. While most HER2 testing is straightforward using ASCO-CAP interpretation guidelines, 5% of cases fall into the… read more here.
Keywords: her2 testing; challenging her2; her2 cases; her2 ... See more keywords